DFX Intelligence
Reading the graph
Reading the graph
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Family Office Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Manages investments for J•••• H• S••••• and M•••••• S••••• and their associated foundations family
New York, NY
Data as of (this record's last observation) from federal regulator filings, dfx's own graph. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Target | State | Kind | Asset class | Sector | Announced | Amount | Evidence |
|---|---|---|---|---|---|---|---|
| N••• B•• | n/a | Round participation | n/a | n/a | Jun 22, 2026 | n/a | fact |
| R••••• F•••• | n/a | Round participation | n/a | n/a | Dec 2, 2025 |
| Person | Title | Role | Seniority | Family member | Current | Evidence |
|---|---|---|---|---|---|---|
| J••••• C••••• | Manager | leadership | senior | n/a | yes | fact |
| A••••• C•••••• | President | leadership | senior | no | yes | fact |
| M•••••• M••••• |
| fact |
| N•••••• T••••••••• | n/a | Round participation | n/a | n/a | Apr 3, 2025 | n/a | fact |
| N•••••• T••••••••• | n/a | Round participation | n/a | n/a | Feb 8, 2024 | n/a | fact |
| P•• P••••••••• I••• | n/a | 13G beneficial ownership stake | public equity | healthcare/biotech | Apr 28, 2021 | n/a | fact |
| P•• P••••••••• I••• | n/a | Public stake 13g | Public equity | n/a | Sep 24, 2020 | n/a | fact |
| C•••••••• | n/a | private investment | private equity/venture | biotech / Covid-19 vaccine | n/a | n/a | fact |
| D•••••• T••••••••• | n/a | venture financing round | private equity/venture | data privacy | n/a | n/a | fact |
| A•••••• | n/a | public equity stake | public equity | healthcare | n/a | n/a | fact |
| D•••••••• | n/a | financing round | private equity/venture | aerial data management | n/a | n/a | fact |
| P•••••••• | n/a | follow-on stake increase | private equity/venture | deep-learning platform | n/a | n/a | fact |
| R••• T••••••••• | n/a | public equity stake | public equity | healthcare | n/a | n/a | fact |
| D•••••• | n/a | private investment | private equity/venture | ML-based diagnostics | n/a | n/a | fact |
| A•••• | n/a | follow-on stake increase | private equity/venture | AI for call centres | n/a | n/a | fact |
| other |
| unknown |
| no |
| yes |
| fact |
| M•••••• S••••• | n/a | Family principal | senior | yes | yes | fact |
| J•••• H• S••••• | President | Family principal | senior | yes | no | fact |
Also named here, with no published line of their own (reach them through the firm): M•••••• M••••• (Head of Investment Strategy), A••••• C•••••• (President), M•••••• S•••••.
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan